Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS | NEJM nejm.org'Truly remarkable' drug helps motor neurone disease BBCBiogen says ALS drug shows clinical benefit in new data analysis ReutersInvestigational ALS Drug Betters Biomarkers, but Can It Improve Motor Functions? Medpage TodayTofersen for SOD1 ALS | NEJM nejm.orgView Full Coverage on Google News